- An improved method for the detection of α2-antiplasmin activity on the automated coagulation analyzer MLA Electra 1000C
- Genistein reduces tumor necrosis factor α-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells
- Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1): Conditions and therapeutic targets
- Fibrinolytic properties of low and high molecular weight single-chain urokinase-type plasminogen activator
- Pharmacological modulation of the endotoxin-induced increase in plasminogen activator inhibitor activity in rats
- The rationale of prevention of thrombosis by enhancing blood levels of single-chain urokinase-type plasminogen activator (scuPA)
- Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products
- Bispecific monoclonal antiboldies increase the fibrin-specific fibrinolytic activity of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)